Assyro AI

FDA Orange Book · active-ingredient family

Thiothixene

Thiothixene is approved as 1 brand and 16 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:NAVANE · NDA 016584

1

Brand (NDA)

16

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
NAVANERLD×5PFIZERNDA 016584Approved Prior to Jan 1, 1982

Generic (ANDA) products (16)

ProductApplicantApplicationTEApproved
THIOTHIXENE×4AMNEALANDA 215456ABFeb 28, 2022
THIOTHIXENE×4NOVITIUM PHARMAANDA 211642ABApr 05, 2019
THIOTHIXENEAM THERAPANDA 072200Dec 17, 1987
THIOTHIXENEAM THERAPANDA 071884Aug 12, 1987
THIOTHIXENEAM THERAPANDA 071885Aug 12, 1987
THIOTHIXENEAM THERAPANDA 071886Aug 12, 1987
THIOTHIXENEAM THERAPANDA 071887Aug 12, 1987
THIOTHIXENEWATSON LABSANDA 071626Jun 25, 1987
THIOTHIXENEWATSON LABSANDA 071627Jun 25, 1987
THIOTHIXENEWATSON LABSANDA 071628Jun 25, 1987
THIOTHIXENE×4EPIC PHARMA LLCANDA 071529Jun 24, 1987
THIOTHIXENE×4RISINGANDA 071093ABJun 23, 1987
THIOTHIXENECHARTWELL RXANDA 070600Jun 05, 1987
THIOTHIXENECHARTWELL RXANDA 070601Jun 05, 1987
THIOTHIXENECHARTWELL RXANDA 070602Jun 05, 1987
THIOTHIXENECHARTWELL RXANDA 070603Jun 05, 1987

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Thiothixene — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.